Cardiol Therapeutics Inc. (CRDL:NASDAQ) closed at $1.10 on October 16, 2026, down 4.35% on the day. The stock trades 53.0% below its 52-week high of $2.34 and 25.0% above its 52-week low of $0.880. Over the past year, it gained 6.8%. Cardiol Therapeutics Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -6.78% | -40.86% | -10.93% | -27.15% | +6.80% |
In 252 trading sessions since October 16, 2025, CRDL closed higher on 111 days (44%). Its best day was October 21, 2025 (+15.24%) and its worst was September 10, 2026 (-13.35%). The stock moved 10% or more in a single session 7 times.
Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, CVD. The CardiolRx is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old.
Find more stocks like CRDL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.